Categories: DiagnosticsNews

NAYO Captivates Audiences at Analytica China 2024 with its Unique Exhibition Style

SHANGHAI, Nov. 20, 2024 /PRNewswire/ — NAYO proudly participated in the 12th Analytica China & Labtech China Congress 2024, the international trade fair for laboratory technology, analysis and biotechnology in China. Breaking away from traditional exhibition norms, NAYO demonstrated its cutting-edge technology and flexible platform-based approach using a robotic arm extending up to 8 meters, capturing the attention of industry experts and attendees alike.

This event marked the global introduction of our Flexible Platform Architecture (FPA), which features a versatile and scalable design. Our modular pipetting modules, ranging from 1 to 96, including single channel, fixed 8-channle / 24-channel / 96-channel pipetting modules and robotic arms including independent 2-channle / 4 channel / 8-channel /12-channel pipetting modules offer uniform performance characteristics across all configurations:

  • Wide range: 1-1000µLfull scale coverage
  • High precision & accuracy: Precision CV≤4% for 5µL, Accuracy ±4%
  • Real-time pipetting monitoring: liquid level detection (pLLD) for accurate and safe pipetting
  • Exclusive sealing design: increases comprehensive service life to over 300,000 cycles
  • Realization of cable-free after-sales service: the unique pogo pin quick-connect design allows for fast module switching to adapt to different needs and also facilitates maintenance

Chandler Luo, Chief Executive Officer of NAYO, said, “Based on our flexible platform, we can provide more than 240 configurations. This event is a fantastic platform for showcasing NAYO’s liquid handlers and powerful innovation technology to a global audience. We hope to engage in meaningful discussions on cooperation with partners and leading medical institutions worldwide.”

To date, NAYO’s products have been exported to more than 10 countries and regions. Moving forward, NAYO will actively expand its global market presence by providing users with more customer-defined products and professional services, offering globally competitive integrated solutions for life science and clinical diagnosis fields.

About NAYO

Founded in 2016, NAYO is a flexible-based-platform manufacturer of laboratory automation which headquartered in Shanghai, China, and also an original equipment manufacturer (OEM). Based on our platform, we offer more than 240 configurations. Our products cover five categories: liquid handling platforms, integrated equipment, integrated modules, exclusive application products and consumables & accessories. In the future, NAYO will focus on global innovation in laboratory efficiency and convenience, continuously improving products, solutions, and research to enhance quality, efficiency, and safety in life sciences and clinical diagnostics.

Please follow our LinkedIn (linkedin.com/company/nayo-biotec) and visit our website at www.nayolab.com for more information.

Contact Information:

NAYO Biotechnology (Shanghai) Co., Ltd
Iris Lin
linfengyin@nayolab.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nayo-captivates-audiences-at-analytica-china-2024-with-its-unique-exhibition-style-302309315.html

SOURCE NAYO Biotechnology (Shanghai) Co., Ltd

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

7 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

10 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

10 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

10 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

10 hours ago